Pharmafile Logo
Pharmafocus logo
Advanced Search

VBP negotiations ‘opened up’

February 19, 2013
Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP

Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …

News

Vasella forgoes golden handshake after furore

February 19, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Vasella

Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …

News
GSK image

GSK plans greater use of biocatalysis, continuous processing

February 19, 2013
Manufacturing and Production GSK, Witty, biocatalysis

GlaxoSmithKline says it is turning to technology to help improve the cost efficiency of its manufacturing operations, including greater use …

News
michel_dubery

inVentiv Health names new European head

February 19, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health

Michel Dubery has been named as the new managing director of inVentiv Health Communications in Europe. Dubery brings more than …

Appointment
EMA image

EU orphan designations rise

February 19, 2013
Research and Development, Sales and Marketing COMP, EMA, Orphan, hta

The number of orphan drug designations in the EU is set to rise to record levels this year, according to …

News

New director at Havas PR

February 19, 2013
Medical Communications Havas, Louise Stone, PR

Havas PR has brought in healthcare consultant Louise Stone to strengthen its health and wellness business. Louise takes on the role …

News

Genzyme’s Waterford plant gets new investment round

February 19, 2013
Manufacturing and Production Genzyme, Sanofi, Waterford

Sanofi’s Genzyme unit plans to spend €44 million on upgrading its plant in Waterford, Ireland, to help meet demand for …

News
Gilead image

Gilead recalls Vistide on particle contamination

February 19, 2013
Manufacturing and Production Gilead, Vistide

Gilead Sciences has issued a voluntary recall of one lot of its antiviral treatment Vistide after finding particulate matter in …

News
Takeda HQ image

CMO plant shut down after Takeda product recall

February 19, 2013
Manufacturing and Production CMP, OPG, Takeda

Japan’s regulatory authorities flexed their enforcement muscles last week when it ordered a temporary shutdown of the contract manufacturer for …

News

ViiV HIV drug boost

February 18, 2013
Sales and Marketing Dolutegravir, GSK, HIV, ViiV

ViiV Healthcare has received a boost with the news that the FDA is to give a priority review to its …

News
merck_and_co

Merck makes $688m payout

February 18, 2013
Sales and Marketing ENHANCE, Inegy, Merck, Vytorin, investors

Merck has paid out $688 million to end two class-action lawsuits which sprang up after the revelation of disappointing trial …

News
novartis image

Another approval for Novartis’ everolimus

February 18, 2013
Sales and Marketing Certican, Novartis, Zortress, everolimus

Novartis has gained US approval for its drug Zortress (everolimus) to prevent liver transplant rejection.Zotress is already used to prevent …

News
Lantus image

Insulin blockbusters targeted by biosimilar blitz

February 15, 2013
Research and Development, Sales and Marketing Biocon, Humalog, Mylan, insulin

Mylan and Biocon are the latest companies to announce major new plans to develop and market biosimilars. The firms are …

News
janssen image

Janssen launches dementia prize

February 15, 2013
Sales and Marketing Hunt, Janssen, NHS, dementia

Janssen has joined forces with the NHS to launch a scheme to financially reward solutions which can help the lives …

News
cameron image

Fundraising to fuel e-Therapeutics’ ‘network pharmacology’

February 15, 2013
Research and Development e-Therapeutics

Drug discovery and development firm e-Therapeutics hopes to raise £40 million via a new share offer to fund its research …

News

Lancet sparks agency row

February 15, 2013
Medical Communications, Sales and Marketing ABPI, Lancet, Luther Pendragon, Marlboro, Phillip Morris

Communications agency Luther Pendragon has parted company with cigarette firm Philip Morris after attention was drawn to the agency’s other …

News
screen_shot_2013-02-15_at_14

Nanobiotix appoints ex-Sanofi head Alain Herrera

February 14, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, nanobiotix

Nanomedicine firm Nanobiotix has announced that Dr Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun …

Appointment

BMS hires Ann Powell Judge from Shire

February 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Powell Judge, BMS, Shire

BMS has announced that Ann Powell Judge will join the company as senior vice president, Human Resources.From March Judge will …

Appointment
Shire image

Shire ADHD drug for UK

February 14, 2013
Sales and Marketing ADHD, Shire, Vyvanse, elvanse

Shire’s attention-deficit hyperactivity disorder (ADHD) drug Elvanse has been given the go-ahead for use in the UK. Elvanse (lisdexamfetamine dimesylate), …

News
cost value image

Delivering value in cost-constrained healthcare environments

February 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, MSI, NHS, VBP, austerity, value

As millions of pounds, euros and dollars are cut from healthcare budgets around the world – driven by austerity measures …

Feature
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026